Skip to content

Comparative study on the reliability and acceptability of AI subjective refraction and traditional subjective refraction

Comparative study on the reliability and acceptability of AI subjective refraction and traditional subjective refraction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098228
Enrollment
Unknown
Registered
2025-03-04
Start date
2025-03-06
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive error

Interventions

Experimental group B(EyeroboVS refractor+AI determination):None
Experimental group A(Automatic refractor+AI determination):None
Control group(Automatic refractor+ Traditional subjective determination):None

Sponsors

Shenyang He Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Age 18 to 40 years old and able to complete all examinations related to this study; 2.Diopter requirement: myopia degree less than 600 degrees and myopia astigmatism degree less than 200 degrees; 3.No amblyopia, strabismus, or other related eye diseases affecting vision; 4.There was no history of ocular surgery, trauma, or systemic or ocular drug use that might have affected the results; 5.Stop wearing soft contact lenses for more than 1 week and hard contact lenses for more than 3 weeks; 6.Volunteer to participate in this clinical trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who are not suitable for optometry; 2.Patients who with one eye that fits the criteria; 3.Patients who are unable to cooperate with both tests.

Design outcomes

Primary

MeasureTime frame
Spherical equivlent;

Countries

China

Contacts

Public ContactLi Yang

Shenyang He Eye Hospital

liyang01@hsyk.com.cn+86 158 4019 9121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026